Site icon pharmaceutical daily

CROs (Clinical Research Organizations) Training Course: Identification, Selection, and Management for Maximum Results & Value (December 1-2, 2022) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “CROs (Clinical Research Organizations) – Identification, Selection, and Management for Maximum Results & Value” training has been added to ResearchAndMarkets.com’s offering.

This CRO training provide all the specific methodology and management techniques to successfully outsource pharmaceutical programs completed on time, within budget, most importantly completed with high level of quality and performance.

This course will provide the attendees with all the specific methodology and management techniques to successfully outsource pharmaceutical programs, that are completed on time, within budget, and most importantly completed with a high level of quality and performance.

Participants will gain an in depth perspective focused on the components of performance and quality based management of drug development. Participants will learn how the current external and internal forces are shaping the way projects will need to be delivered to be competitive and cost efficient, given the state of the industry.

Specific attention will be given to defining meaningful Key Performance Indicators (KPI’s), implementing those indicators into the process, and gathering/analyzing data to proactively deliver quality studies.

Pharmaceutical and Biotechnology research managers and their counterparts in the CRO industry will gain a thorough understanding of how to work together through implementing outsourcing scorecards to achieve successful outsourcing programs.

The processes in managing CROs, including study plans, in-field site visits, preparation for inspections, monitoring evaluation programs, progress and conditions for terminating the services of a CRO will be analyzed along with the overall requirements of data quality assurance. Solutions to problem assessment and correction involving all outsourcing projects along with the legal requirements of sponsors and CROs will be discussed.

Learning Objectives

Ultimately, the challenge facing pharmaceutical companies today is to pursue two seemingly incompatible goals; maintain or increase quality products, while dramatically reducing costs and development lead times.

With those overall goals in mind, participants will learn all the necessary material for identifying and selecting the right CRO for each segment of the research targeted for outsourcing. Pharmaceutical personnel will learn the techniques required for successfully managing CROs and the shared responsibilities required from the sponsor and the service provider. CRO personnel will gain the full understanding of what is expected of them, in the new drug development process.

Who Should Attend:

This 2-day virtual workshop is designed for personnel in the Pharmaceutical, Biotechnology, Medical Device and Biologics industries who use Contract Research Organizations (CROs) in the process of developing their products for Healthcare Authority approval globally. Attendees should have a basic knowledge of drug, device or biologics development processes and a need to understand what is involved in outsourcing non-clinical and clinical research to CROs.

The following issues will be discussed:

Participants will understand

Key Topics Covered:

Day 1 Agenda

Introduction to Clinical Research Organizations.

Sponsor Action Plan “Setting the stage for success”.

CRO Vendor Selection Process.

Development Checklist and evaluation “Heat Map” development.

Site management and why it matters.

Day 2 Agenda

Managing CROs.

Duties of the CRO, Sponsor and Trial Sites.

Troubleshooting

Key Topics Covered:

Kelly Thomas

Vice President

Stallergenes Greer

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.

For more information about this training visit https://www.researchandmarkets.com/r/izrf7g

 

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version